Both in Biotechnology
Armata Pharmaceuticals vs LENZ Therapeutics
Over the past year ARMP returned −35.1% and LENZ returned −87.7%; their daily moves had a correlation of 0.09.
ARMP −35.1% LENZ −87.7%Growth of $1, one year, split-adjusted
| Metric | ARMP | LENZ |
|---|---|---|
| Price | $3.14 | $3.46 |
| Market cap | $116.8M | $108.7M |
| Today | +1.62% | −1.14% |
| 1 month | −18.4% | −8.7% |
| 6 months | −65.3% | −64.3% |
| Year to date | −50.0% | −78.4% |
| 1 year | −35.0% | −87.6% |
| Revenue growth (YoY) | +15.7% | +9.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | 2953.8% | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | 5.1× |
| Net cash | -$259.6M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 114.9% | 75.9% |
| Short % of float | 4.4% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).